Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator
By Colin Kellaher
Medtronic has won Food and Drug Administration approval of its Inceptiv closed-loop rechargeable spinal cord stimulator, or SCS, to treat chronic pain.
Medtronic on Friday said Inceptiv is its first SCS device to offer a closed-loop feature that senses biological signals along the spinal cord and automatically adjusts stimulation in real time.
The Dublin-based company said Inceptiv adjusts for movements such as laughing, bending or sneezing that can result in brief moments of uncomfortable overstimulation from traditional fixed-output SCS devices, which in turn may lead some patients to turn down their device's stimulation output.
Medtronic plans to initiate the U.S. market launch of Inceptiv, which was previously approved for sale in Europe and Japan, in the coming weeks.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
April 26, 2024 08:56 ET (12:56 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What Does Nvidia’s Stock Split Mean for Investors?
-
5 Undervalued Stocks to Buy as Their Stories Play Out
-
Markets Brief: Return of the Meme Stocks
-
What’s Happening In the Markets This Week
-
It’s Been a Terrible Time for Bonds. Here’s Why You Should Own Them
-
Which AI Stocks Are Turning Hype Into Revenue?
-
Best- and Worst-Performing Stocks of May 2024
-
3 Stocks to Buy and 3 Stocks to Sell in June
-
After Earnings, Is Nio Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Lululemon Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Dividend Stocks
-
The Most Attractive Investment Opportunities in Oil & Gas
-
Apple: Generative AI Strategy Should Drive Sales and Upgrades
-
2 Undervalued Stocks That Just Raised Dividends
-
2 Popular Stocks That Top Managers Are Selling
-
The Best REITs to Buy